Authors:
Valent, F
Schernthaner, GH
Sperr, WR
Fritsch, G
Agis, H
Willheim, M
Buhring, HJ
Orfao, A
Escribano, L
Citation: F. Valent et al., Variable expression of activation-linked surface antigens on human mast cells in health and disease, IMMUNOL REV, 179, 2001, pp. 74-81
Authors:
Jordan, JH
Walchshofer, S
Jurecka, W
Mosberger, I
Sperr, WR
Wolff, K
Chott, A
Buhring, HJ
Lechner, K
Horny, HP
Valent, P
Citation: Jh. Jordan et al., Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-x(L), HUMAN PATH, 32(5), 2001, pp. 545-552
Authors:
Moris, A
Teichgraber, V
Gauthier, L
Buhring, HJ
Rammensee, HG
Citation: A. Moris et al., Cutting edge: Characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection, J IMMUNOL, 166(8), 2001, pp. 4818-4821
Authors:
Fureder, W
Schernthaner, GH
Ghannadan, M
Hauswirth, A
Sperr, WR
Semper, H
Majlesi, Y
Zwirner, J
Gotze, O
Buhring, HJ
Lechner, K
Valent, P
Citation: W. Fureder et al., Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes, EUR J CL IN, 31(10), 2001, pp. 894-901
Authors:
Brossart, P
Schneider, A
Dill, P
Schammann, T
Grunebach, F
Wirths, S
Kanz, L
Buhring, HJ
Brugger, W
Citation: P. Brossart et al., The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-Lymphocytes, CANCER RES, 61(18), 2001, pp. 6846-6850
Authors:
Seiffert, M
Brossart, P
Cant, C
Cella, M
Colonna, M
Brugger, W
Kanz, L
Ullrich, A
Buhring, HJ
Citation: M. Seiffert et al., Signal-regulatory protein alpha (SIRP alpha) but not SIRP beta is involvedin T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells, BLOOD, 97(9), 2001, pp. 2741-2749
Authors:
Buhring, HJ
Seiffert, M
Giesert, C
Marxer, A
Kanz, L
Valent, P
Sano, K
Citation: Hj. Buhring et al., The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3, BLOOD, 97(10), 2001, pp. 3303-3305
Authors:
Scheding, S
Meister, B
Buhring, HJ
Baum, CM
McKearn, JP
Bock, T
Kanz, T
Brugger, W
Citation: S. Scheding et al., Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells, EXP HEMATOL, 28(4), 2000, pp. 460-470
Authors:
Kratz-Albers, K
Scheding, S
Mohle, R
Buhring, HJ
Baum, CM
Mc Kearn, JP
Buchner, T
Kanz, L
Brugger, W
Citation: K. Kratz-albers et al., Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin, EXP HEMATOL, 28(3), 2000, pp. 335-346
Authors:
Doyonnas, R
Chan, JYH
Butler, LH
Rappold, I
Lee-Prudhoe, JE
Zannettino, ACW
Simmons, PJ
Buhring, HJ
Levesque, JP
Watt, SM
Citation: R. Doyonnas et al., CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor, J IMMUNOL, 165(2), 2000, pp. 840-851
Authors:
Dietrich, J
Cella, M
Seiffert, M
Buhring, HJ
Colonna, M
Citation: J. Dietrich et al., Cutting edge: Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells, J IMMUNOL, 164(1), 2000, pp. 9-12
Authors:
Watt, SM
Butler, LH
Tavian, M
Buhring, HJ
Rappold, I
Simmons, PJ
Zannettino, ACW
Buck, D
Fuchs, A
Doyonnas, R
Chan, JYH
Levesque, JP
Peault, B
Roxanis, I
Citation: Sm. Watt et al., Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues, BLOOD, 95(10), 2000, pp. 3113-3124
Authors:
Schumm, M
Lang, P
Taylor, G
Kuci, S
Klingebiel, T
Buhring, HJ
Geiselhart, A
Niethammer, D
Handgretinger, R
Citation: M. Schumm et al., Isolation of highly purified autologous and allogeneic peripheral CD34(+) cells using the CliniMACS device, J HEMATOTH, 8(2), 1999, pp. 209-218
Authors:
Brugger, W
Buhring, HJ
Grunebach, F
Vogel, W
Kaul, S
Muller, R
Brummendorf, TH
Ziegler, BL
Rappold, I
Brossart, P
Scheding, S
Kanz, L
Citation: W. Brugger et al., Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumor cells, J CL ONCOL, 17(5), 1999, pp. 1535-1544
Authors:
Buhring, HJ
Simmons, PJ
Pudney, M
Muller, R
Jarrossay, D
van Agthoven, A
Willheim, M
Brugger, W
Valent, P
Kanz, L
Citation: Hj. Buhring et al., The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors, BLOOD, 94(7), 1999, pp. 2343-2356
Authors:
Buhring, HJ
Seiffert, M
Marxer, A
Weiss, B
Faul, C
Kanz, L
Brugger, W
Citation: Hj. Buhring et al., AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34(+) B-cell precursors, BLOOD, 94(2), 1999, pp. 832-833
Authors:
Seiffert, M
Cant, C
Chen, ZJ
Rappold, I
Brugger, W
Kanz, L
Brown, EJ
Ullrich, A
Buhring, HJ
Citation: M. Seiffert et al., Human signal-regulatory protein is expressed on normal, but not on subsetsof leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47, BLOOD, 94(11), 1999, pp. 3633-3643
Authors:
Brach, MA
Buhring, HJ
Gruss, HJ
Ashman, LK
Ludwig, WD
Mertelsmann, RH
Herrmann, F
Citation: Ma. Brach et al., Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein (Retraction of vol 80, pg 1224, 1992), BLOOD, 93(10), 1999, pp. 3573-3573